Phase I trial of a novel anti-GD2 monoclonal antibody, hu14.18K322A, designed to decrease toxicity in children with refractory or recurrent neuroblastoma
- Fariba Navid
- , Paul M. Sondel
- , Raymond Barfield
- , Barry L. Shulkin
- , Robert A. Kaufman
- , Jim A. Allay
- , Jacek Gan
- , Paul Hutson
- , Songwon Seo
- , Kyung Mann Kim
- , Jacob Goldberg
- , Jacquelyn A. Hank
- , Catherine A. Billups
- , Jianrong Wu
- , Wayne L. Furman
- , Lisa M. McGregor
- , Mario Otto
- , Stephen D. Gillies
- , Rupert Handgretinger
- , Victor M. Santana
Research output: Contribution to journal › Article › peer-review
153
Link opens in a new tab
Scopus
citations